| RH133036 |
Emtricitabine |
Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC5
|
| RH133037 |
GPS491 |
GPS491 (EC50 = 0.47 μM) suppresses expression of the HIV-1 structural protein Ga
|
| RH133038 |
TTBK1-IN-2 |
TTBK1-IN-2 (compound 29) is a potent Tau-Tubulin kinase (TTBK1) inhibitor with I
|
| RH133039 |
somatostatin |
Somatostatin
|
| RH133040 |
Sodium houttuyfonate |
Sodium Houttuyfonate
|
| RH133041 |
retro-Methyl-a-ionol |
retro-Methyl-α-ionol
|
| RH133042 |
Isocarboxazid |
Isocarboxazid is a non-selective and irreversible inhibitor of monoamine oxidase
|
| RH133043 |
Vimseltinib |
Vimseltinib (DCC-3014) is a c-FMS (CSF-IR) and c-Kit dual inhibitor extracted fr
|
| RH133044 |
Phentolamine Mesylate |
Phentolamine mesylate (Phentolamine methanesulfonate) is a reversible, non-selec
|
| RH133045 |
CW 008 |
CW 008, a derivative of pyrazole-pyridine, is a CREB or PKA pathway agonist.
|
| RH133046 |
Ilginatinib |
Ilginatinib (NS-018) is a highly active and orally bioavailable JAK2 inhibitor,
|
| RH133047 |
Ilginatinib hydrochloride |
Ilginatinib hydrochloride (NS-018 hydrochloride) is a highly active and orally b
|
| RH133048 |
Trandolapril |
Trandolapril (RU44570) is a nonsulfhydryl proagent that is hydrolysed to the act
|
| RH133049 |
VLX600 |
VLX600 is an iron-chelating inhibitor of oxidative phosphorylation (OXPHOS).
|
| RH133050 |
Tirbanibulin Mesylate |
Tirbanibulin Mesylate (KX2-391 Mesylate) is an inhibitor of Src that targets the
|
| RH133051 |
Paritaprevir (ABT-450) |
Paritaprevir (ABT-450) is a potent, orally active and antiviral non-structural p
|
| RH133052 |
SAG hydrochloride |
SAG hydrochloride is a potent Smoothened (Smo) receptor agonist (EC50=3 nM; Kd=5
|
| RH133053 |
Xanomeline tartrate |
Xanomeline (LY 246708) is the potent agonist of muscarinic M1/M4 receptor with a
|
| RH133054 |
Difamilast |
Difamilast (OPA-15406) is a topical, selective and nonsteroidal phosphodiesteras
|
| RH133055 |
Nafoxidine Hydrochloride |
Nafoxidine hydrochloride is a non-steroidal estrogen receptor antagonist with an
|
| RH133056 |
Xanomeline( LY-246708) |
Xanomeline, as an effective and selective muscarinic type 1 and type 4 (M1/M4) r
|
| RH133057 |
Benzamide, N-(cyanomethyl)-4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]-, hydrochloride, hydrate (1:2:1) |
Benzamide, N-(cyanomethyl)-4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]-
|
| RH133058 |
Asciminib |
Asciminib (ABL001) is a potent and selective allosteric BCR-ABL1 inhibitor, whic
|
| RH133059 |
Lasofoxifene |
Lasofoxifene (CP-336156) is an orally active and selective estrogen receptor mod
|
| RH133060 |
Lasofoxifene tartrate |
Lasofoxifene (CP-336156) tartrate is an orally active and selective estrogen rec
|